Effect of composition in the development of carbamazepine hot-melt extruded solid dispersions by application of mixture experimental design

Journal of Pharmacy and Pharmacology

Volumn 66, Issue 2, 2014, Pages 232-243

  Djuris, Jelena ^a   Ioannis, Nikolakakis ^b   Ibric, Svetlana ^a   Djuric, Zorica ^a   Kachrimanis, Kyriakos ^b  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

carbamazepine; mixture design; Poloxamer 407; solid dispersion; Soluplus

Indexed keywords

CARBAMAZEPINE; COPOLYMER; POLOXAMER; POLYETHYLENEGLYCOLPOLYVINYL CAPROLACTAM POLYVINYL ACETATE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DISSOLUTION; DRUG FORMULATION; DRUG MANUFACTURE; DRUG MIXTURE; DRUG RELEASE; EXPERIMENTAL STUDY; HOT MELT EXTRUSION; PROCESS DEVELOPMENT; REFLECTOMETRY;

CARBAMAZEPINE; MIXTURE DESIGN; POLOXAMER 407; SOLID DISPERSION; SOLUPLUS;

CARBAMAZEPINE; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; DRUG COMPOUNDING; DRUG STABILITY; FREEZING; HARDNESS; HOT TEMPERATURE; HUMANS; PLASTICIZERS; POLOXAMER; POLYETHYLENE GLYCOLS; POLYVINYLS; SOLUBILITY; SOLUTIONS;

EID: 84892766139     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/jphp.12199     Document Type: Article

References (33)

1. Breitenbach J,. Melt extrusion: from process to drug delivery technology. Eur J Pharm Biopharm 2002; 54: 107-117.
2. Chokshi R, Zia H,. Hot-melt extrusion technique: a review. Iran J Pharm Res 2004; 3: 3-16.
3. McGinity JW, et al. Hot-melt extrusion technology. In:, Swarbrick J, ed. Encyclopedia of Pharmaceutical Technology, 3rd edn. New York: Informa Healthcare, 2007: 2004-2020.
4. Crowley MM, et al. Pharmaceutical applications of hot-melt extrusion: part I. Drug Dev Ind Pharm 2007; 33: 909-926.
5. Shah S, et al. Melt extrusion with poorly soluble drugs. Int J Pharm 2013.
6. Leuner C, Dressman J,. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm 2000; 50: 47-60.
7. Kovacevic I, et al. Justification of biowaiver for carbamazepine, a low soluble high permeable compound, in solid dosage forms based on IVIVC and gastrointestinal simulation. Mol Pharm 2008; 6: 40-47.
8. Sweetman S, (ed.). Martindale: The Complete Drug Reference, 37th edn, CD-ROM. London: Pharmaceutical Press, 2007.
9. Doshi DH, et al. Carbamazepine and polyethylene glycol solid dispersions: preparation, in vitro dissolution, and characterization. Drug Dev Ind Pharm 1997; 23: 1167-1176.
10. Zerrouk N, et al. In vitro and in vivo evaluation of carbamazepine-PEG 6000 solid dispersions. Int J Pharm 2001; 225: 49-62.
11. El-Zein H, et al. Enhancement of carbamazepine dissolution: in vitro and in vivo evaluation. Int J Pharm 1998; 168: 209-220.
12. Perissutti B, et al. Preparation of extruded carbamazepine and PEG 4000 as a potential rapid release dosage form. Eur J Pharm Biopharm 2002; 53: 125-132.
13. Sethia S, Squillante E,. Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods. Int J Pharm 2004; 272: 1-10.
14. Rane Y, et al. Effect of hydrophilic swellable polymers on dissolution enhancement of carbamazepine solid dispersions studied using response surface methodology. AAPS PharmSciTech 2007; 8: E1-E11.
15. Patterson JE, et al. Melt extrusion and spray drying of carbamazepine and dipyridamole with polyvinylpyrrolidone/vinyl acetate copolymers. Drug Dev Ind Pharm 2008; 34: 95-106.
16. Hardung H, et al. Combining HME & solubilization: Soluplus®-the solid solution. Drug Deliv Technol 2010; 10.
17. Djuris J, et al. Preparation of Carbamazepine-Soluplus® solid dispersions by hot-melt extrusion, and prediction of drug-polymer miscibility by thermodynamic model fitting. Eur J Pharm Biopharm 2013; 84: 228-237.
18. Lu J, et al. Solid dispersions of carbamazepine with Lutrol® F127 using hot melt extrusion. 39th CRS Annual Meeting & Exposition, Centre des Congrès de Québec, Québec City, Canada (abstract ID: 100626), 2012.
19. ICH Topic Q8(R2). Guidance for Industry: Pharmaceutical Development. 2009. Accessed March 1, 2013, at: http://www.ich.org/fileadmin/Public-Web-Site/ ICH-Products/Guidelines/Quality/Q8-R1/Step4/Q8-R2-Guideline.pdf
20. Dhumal RS, et al. Cocrystalization and simultaneous agglomeration using hot melt extrusion. Pharm Res 2010; 27: 2725-2733.
21. Hinkelmann K, Kempthorne O,. Designs and Analysis of Experiments, Vol. 1. New York: John Wiley and Sons Inc, 2007.
22. Lewis GA, et al. Mixtures in a constrained region of interest. In:, Swarbrick J, ed. Pharmaceutical Experimental Design. New York: Marcel Dekker, 1999: 413-454.
23. Anderson M, (ed.). Mixture Design Tutorial (Part 1-The Basics). Design-Expert software Version 7.1 User's Guide, 2007.
24. Esbensen KH, et al. Multivariate Data Analysis-in Practice: An Introduction to Multivariate Data Analysis and Experimental Design. Esbjerg: CAMO Software, Aalborg University, 2002.
25. Wang L, et al. Physical assessment of composite biodegradable films manufactured using whey protein isolate, gelatin and sodium alginate. J Food Eng 2010; 96: 199-207.
26. Akalin O, et al. Optimization of chemical admixture for concrete on mortar performance tests using mixture experiments. Chemom Intell Lab Syst 2010; 104: 233-242.
27. Kipouros K, et al. Simultaneous quantification of carbamazepine crystal forms in ternary mixtures (I, III and IV) by diffuse reflectance FTIR spectroscopy (DRIFTS) and multivariate calibration. J Pharm Sci 2006; 95: 2419-2431.
28. Grzesiak AL, et al. Comparison of the four anhydrous polymorphs of carbamazepine and the crystal structure of form I. J Pharm Sci 2003; 92: 2260-2271.
29. Silverstein RM, et al. Spectrometric Identification of Organic Compounds, 7th edn. Hoboken, NJ: John Wiley & Sons, 2006.
30. Kobayashi Y, et al. Physicochemical properties and bioavailability of carbamazepine polymorphs and dehydrate. Int J Pharm 2000; 193: 137-146.
31. Djuric D, Kolter K,. Bioavailability enhancement of fenofibrate and itraconazole by forming solid solutions with an innovative amphiphilic copolymer. PBP World Meeting, Malta, Valletta, 2010.
32. Kalivoda A, et al. Application of mixtures of polymeric carriers for dissolution enhancement of oxeglitazar using hot-melt extrusion. Int J Pharm 2012; 439: 145-156.
33. Shaukat A, et al. Eye on excipients: soluplus, a novel graft copolymer. Tabl Caps 2010; 10.